Who
Kevin Andrew Robbins
Director
Company insider
Files Form 4 as: Director, Mannatech.
In numbers
- Trades disclosed
- 31
- Buys
- 3
- Sells
- 9
- Bought
- $84K
- Sold
- $261K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Dec 2016
- Last trade
- 19 May 2026
- Last filed
- 20 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 20 May 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $30K7,100 at $4.17 | filing |
| 19 May 2026filed 20 May 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $30K7,100 at $4.17 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2025filed 6 Jan 2025 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,686 at $14.89 | filing |
| 12 Jun 2024filed 14 Jun 2024 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 2 Jan 2024filed 5 Jan 2024 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,932 at $8.11 | filing |
| 3 Jan 2023filed 5 Jan 2023 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,294 at $17.43 | filing |
| 8 Dec 2022filed 12 Dec 2022 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $33K1,500 at $22.00 | filing |
| 28 Mar 2022filed 30 Mar 2022 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $40K1,100 at $36.57 | filing |
| 3 Jan 2022filed 5 Jan 2022 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K1,012 at $39.49 | filing |
| 26 Aug 2021filed 27 Aug 2021 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 26 Aug 2021filed 27 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code M | $86K5,000 at $17.28 | filing |
| 23 Aug 2021filed 24 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $49K1,500 at $32.99 | filing |
| 20 Aug 2021filed 24 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $32K1,000 at $32.24 | filing |
| 19 Aug 2021filed 20 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $16K500 at $31.99 | filing |
| 17 Aug 2021filed 18 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $62K2,000 at $30.83 | filing |
| 17 Aug 2021filed 18 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Sold | $35211 at $31.99 | filing |
| 16 Jun 2021filed 21 Jun 2021 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 4 Jan 2021filed 5 Jan 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K1,873 at $18.68 | filing |
News
Analyzing Edgewell Personal Care (NYSE:EPC) and Mannatech (NASDAQ:MTEX)MTEX · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Kevin Andrew Robbins; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.